FOUNDER & CSO: MICHAEL O’DWYER, MD

    • Professor of Hematology, National University of Ireland, Galway.
    • HRB Clinician Scientist
    • Director SFI Blood Cancer Network Ireland
    • Former Assistant Professor at Oregon Health & Sciences University: worked on development of imatinib.
  • Member of the International Myeloma Working Group (IMWG)

FOUNDER & CHAIRMAN: ANTHONY KILLARNEY

  • Founder KTL, engineering services provider with in excess of 250 employees (1998)
  • Founder and CEO telecoms infrastructure business Towercom (2007)

LEGAL ADVISOR & DIRECTOR: PATRICK O’DWYER

  • Practicing Barrister
  • Commercial accredited Mediator
  • Contract Law specialist
  • Commercial contract negotiator
  • Employment law specialist
  • Founder Docklands Partnership

DIRECTOR: DR. PHILIP O’DWYER

  • Qualified in Galway MB BCh
  • Post graduate specialist training in Obstetrics and Gynaecology(MRCOG) and General Practice (MRCGP)
  • MBA from Smurfit Business School
  • Consultant with McKinsey
  • Bioscience start-up funding with Growcorp
  • Currently General Practitioner and Specialist in fertility

PATENT ATTORNEY & DIRECTOR: GEORGE SCHLICH

  • MA (Cantab); EPA, CPA, CTMA.
  • Patent specialisation in life sciences, pharma and chemistry.
  • Represents patent owners and opponents at inter-parties hearings before the European Patent Office.
  • Selected clients: Intellia Therapeutics, Inc in CRISPR/Cas9 technology and AbbVie, Inc in oncology.

DIRECTOR: EUNAN MAGUIRE

Eunan Maguire is an experienced pharmaceutical executive. Most recently he co-founded Adapt Pharma – a leader in opioid overdose treatment – and served as its Chief Operating Officer until its sale to Emergent BioSolutions. Eunan previously co-founded Azur Pharma – a CNS and Women’s Health Pharmaceutical business – and served as its President until it merged with Jazz Pharmaceuticals. He subsequently led strategy and corporate development at Jazz. Earlier in his career, Eunan was Vice President of business development at King Pharmaceuticals (acquired by Pfizer) and Strategy at Elan Corporation. Eunan is an accountant by profession and trained at KPMG. His board memberships include AixThera, ALSHC and Avectas.